United Therapeutics director Kurzweil receives equity awards
United Therapeutics Corp director Ray Kurzweil received annual equity awards consisting of 380 restricted stock units and 1,190 stock options on July 22, 2026.
Rhea-AI Filing Summary
United Therapeutics Corp director Ray Kurzweil received annual equity awards consisting of 380 restricted stock units and 1,190 stock options on July 22, 2026. The awards vest in full on the earlier of the one-year anniversary of the grant or the next Annual Meeting, anticipated on June 25, 2027. The options carry an exercise price of $527.07 per share and expire on July 22, 2033. Following these awards, he directly holds 13,320 shares of United Therapeutics common stock. The restricted stock units have no expiration date and each converts into one share upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,570 shares
Grant/Award
3 txns
Insider
KURZWEIL RAY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2, F3, F4 | 380 | $0.00 | $0.00 |
| Grant/Award | Stock Option F2, F3 | 1,190 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 380 contracts (Direct);
Stock Option — 1,190 contracts (Direct);
Common Stock — 13,320 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2. Annual non-employee director award.
- F3. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F4. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Restricted stock units granted: 380 units
Stock options granted: 1,190 options
Option exercise price: $527.07 per share
+3 more
6 metrics
Restricted stock units granted
380 units
Annual non-employee director award granted on 2026-07-22
Stock options granted
1,190 options
Annual non-employee director award granted on 2026-07-22
Option exercise price
$527.07 per share
Exercise price for the 1,190 stock options granted
Option expiration date
July 22, 2033
Expiration of stock options granted to Ray Kurzweil
Anticipated vesting/meeting date
June 25, 2027
Anticipated date of next Annual Meeting; awards vest by this date or one-year anniversary
Common shares held after awards
13,320 shares
Directly held United Therapeutics common stock following reported awards
Key Terms
Restricted Stock Unit, Stock Option, Annual non-employee director award, exercise price
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting, one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"Stock Option award covering 1,190.0000 underlying shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Annual non-employee director award financial
"Annual non-employee director award described in the footnotes to the equity grants"
exercise price financial
"Stock option grant with an exercise price of 527.0700 per share of common stock"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did United Therapeutics (UTHR) grant to Ray Kurzweil?
Ray Kurzweil received 380 restricted stock units and 1,190 stock options as annual non-employee director awards. Each restricted stock unit converts into one common share upon vesting, while the options are exercisable for common stock at a fixed price.
What is the exercise price of Ray Kurzweil’s new United Therapeutics (UTHR) stock options?
The granted stock options have an exercise price of $527.07 per share. This is the price at which Kurzweil may purchase United Therapeutics common stock under the option grant once the options are vested and through their stated expiration date.
When do Ray Kurzweil’s new United Therapeutics (UTHR) director awards vest?
The annual director awards become fully vested on the earlier of the one-year anniversary of the July 22, 2026 grant date or the next Annual Meeting. June 25, 2027 is identified as the anticipated date of that next Annual Meeting of Shareholders.
When do Ray Kurzweil’s United Therapeutics (UTHR) stock options expire?
The stock options granted to Ray Kurzweil expire on July 22, 2033. After that expiration date, any unexercised options become worthless, so they are exercisable only between vesting and this stated expiration date, subject to applicable plan and agreement terms.
Do the United Therapeutics (UTHR) restricted stock units granted to Ray Kurzweil have an expiration date?
The restricted stock units reported do not have an expiration date. A footnote clarifies that restricted stock units do not carry an expiration, and each unit instead represents a right to receive one share of common stock after the applicable vesting conditions are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
